Cargando…

Characterization and clinical verification of immune-related genes in hepatocellular carcinoma to aid prognosis evaluation and immunotherapy

BACKGROUND: Immune-related genes (IRGs) have been confirmed to play an important role in tumorigenesis and tumor microenvironment formation in hepatocellular carcinoma (HCC). We investigated how IRGs regulates the HCC immunophenotype and thus affects the prognosis and response to immunotherapy. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qu, Jialin, Sun, Fenghao, Hou, Yichen, Qi, Haoran, Sun, Xiaorong, Xing, Ligang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273514/ https://www.ncbi.nlm.nih.gov/pubmed/37322434 http://dx.doi.org/10.1186/s12885-023-10900-8

Ejemplares similares

Development and verification of the glycolysis-associated and immune-related prognosis signature for hepatocellular carcinoma
por: Hu, Bo, et al.
Publicado: (2022)

Towards an era of precise diagnosis and treatment: Role of novel molecular modification-based imaging and therapy for dedifferentiated thyroid cancer
por: Li, Jing, et al.
Publicado: (2022)

Navigate Towards the Immunotherapy Era: Value of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Brain Metastases
por: Yang, Guanqun, et al.
Publicado: (2022)

Prognostic Role Of Computed Tomography Textural Features In Early-Stage Non-Small Cell Lung Cancer Patients Receiving Stereotactic Body Radiotherapy
por: Zhang, Ran, et al.
Publicado: (2019)

Development and Verification of the Hypoxia-Related and Immune-Associated Prognosis Signature for Hepatocellular Carcinoma
por: Hu, Bo, et al.
Publicado: (2020)

Functional status and spatial interaction of T cell subsets driven by specific tumor microenvironment correlate with recurrence of non-small cell lung cancer
por: Yang, Liying, et al.
Publicado: (2023)

Hepatocellular carcinoma immune prognosis score predicts the clinical outcomes of hepatocellular carcinoma patients receiving immune checkpoint inhibitors
por: Zhang, Rujia, et al.
Publicado: (2023)

Identification, Verification and Pathway Enrichment Analysis of Prognosis-Related Immune Genes in Patients With Hepatocellular Carcinoma
por: Zhu, Zhipeng, et al.
Publicado: (2021)

Immune Cell Infiltration Landscape of Ovarian Cancer to Identify Prognosis and Immunotherapy-Related Genes to Aid Immunotherapy
por: Li, Xiushen, et al.
Publicado: (2021)

Characterization of the Different Subtypes of Immune Cell Infiltration to Aid Immunotherapy
por: Li, Zhenqing, et al.
Publicado: (2022)

Characterization of the immune cell infiltration landscape in myxofibrosarcoma to aid immunotherapy
por: Zhao, Zi-Yue, et al.
Publicado: (2022)

The angiogenic genes predict prognosis and immune characteristics in esophageal squamous cell carcinoma: Evidence from multi-omics and experimental verification
por: Wang, Shuaiyuan, et al.
Publicado: (2022)

Efficacy and safety of immunoradiotherapy for advanced non-small cell lung cancer: a retrospective comparative cohort study
por: Gao, Yifan, et al.
Publicado: (2023)

A preclinical study: correlation between PD-L1 PET imaging and the prediction of therapy efficacy of MC38 tumor with (68)Ga-labeled PD-L1 targeted nanobody
por: Qin, Songbing, et al.
Publicado: (2021)

Functional status and spatial architecture of tumor-infiltrating CD8+ T cells are associated with lymph node metastases in non-small cell lung cancer
por: Yang, Guanqun, et al.
Publicado: (2023)

Comprehensive Analysis of Cellular Senescence-Related Genes in Prognosis, Molecular Characterization and Immunotherapy of Hepatocellular Carcinoma
por: Sun, Liang, et al.
Publicado: (2022)

Characterization of immune features and immunotherapy response in subtypes of hepatocellular carcinoma based on mitophagy
por: Wang, Yanan, et al.
Publicado: (2022)

Characterization of m6A-Related Genes Landscape in Skin Cutaneous Melanoma to Aid Immunotherapy and Assess Prognosis
por: Meng, Jinzhi, et al.
Publicado: (2021)

Analysis of the Heterogeneity of the Tumor Microenvironment and the Prognosis and Immunotherapy Response of Different Immune Subtypes in Hepatocellular Carcinoma
por: Hu, Jian, et al.
Publicado: (2022)

A novel immune score model predicting the prognosis and immunotherapy response of breast cancer
por: Lv, Wenchang, et al.
Publicado: (2023)

Identification and verification of a novel epigenetic-related gene signature for predicting the prognosis of hepatocellular carcinoma
por: Wang, Chenchen, et al.
Publicado: (2022)

Characterization of the Immune Cell Infiltration Profile in Pancreatic Carcinoma to Aid in Immunotherapy
por: Luo, De, et al.
Publicado: (2021)

Characterization of the immune related lncRNAs in bladder cancer to aid immunotherapy
por: Xiao, Ying, et al.
Publicado: (2022)

Characterization of Different Subtypes of Immune Cell Infiltration in Glioblastoma to Aid Immunotherapy
por: Feng, Peng, et al.
Publicado: (2022)

Development and Verification of the Amino Metabolism-Related and Immune-Associated Prognosis Signature in Gliomas
por: Xu, Yang, et al.
Publicado: (2021)

Verification of genetic differences and immune cell infiltration subtypes in the neuroblastoma tumour microenvironment during immunotherapy
por: Qian, Bo, et al.
Publicado: (2022)

Characterization of the m6A-Associated Tumor Immune Microenvironment in Prostate Cancer to Aid Immunotherapy
por: Liu, Zezhen, et al.
Publicado: (2021)

A necroptosis -related signature for predicting prognosis and immunotherapy in hepatocellular carcinoma
por: Fu, Xing, et al.
Publicado: (2022)

A novel tumor immunotherapy-related signature for risk stratification, prognosis prediction, and immune status in hepatocellular carcinoma
por: Sun, Jianping, et al.
Publicado: (2023)

Microenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinoma
por: Liu, Furong, et al.
Publicado: (2020)

Identification of the Immune Cell Infiltration Landscape in Hepatocellular Carcinoma to Predict Prognosis and Guide Immunotherapy
por: Yang, Shiyan, et al.
Publicado: (2021)

Circulating immune index predicting the prognosis of patients with hepatocellular carcinoma treated with lenvatinib and immunotherapy
por: Guo, De-Zhen, et al.
Publicado: (2023)

Percutaneous Sonazoid-enhanced ultrasonography combined with in vitro verification for detection and characterization of sentinel lymph nodes in early breast cancer
por: Hao, Yunxia, et al.
Publicado: (2021)

Characterization of Fatty Acid Metabolism-Related Genes Landscape for Predicting Prognosis and Aiding Immunotherapy in Glioma Patients
por: Jiang, Feng, et al.
Publicado: (2022)

Prediction of prognosis, immune infiltration, and personalized treatment of hepatocellular carcinoma by analysis of cuproptosis-related long noncoding RNAs and verification in vitro
por: Li, Shanbao, et al.
Publicado: (2023)

Identification and verification of immune-related biomarkers and immune infiltration in diabetic heart failure
por: Zhong, Zuoquan, et al.
Publicado: (2022)

Verification and validation of hearing aids: Opportunity not an obstacle
por: Jorgensen, Lindsey E.
Publicado: (2016)

Computational Recognition and Clinical Verification of TGF-β-Derived miRNA Signature With Potential Implications in Prognosis and Immunotherapy of Intrahepatic Cholangiocarcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

ZCCHC17 Served as a Predictive Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma
por: Liu, Fahui, et al.
Publicado: (2022)

ELOVLs Predict Distinct Prognosis Value and Immunotherapy Efficacy In Patients With Hepatocellular Carcinoma
por: Zhang, Yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n12krc9bs8hc9r6olo21l39ssi